Insiders · Profile

Kelly James Patrick

EVP & Chief Financial Officer at Vanda Pharmaceuticals. Filing since 29 Aug 2011. CIK 0001506314

Company
Date
Role
Action
Shares
Amount
Of holding
3 Mar 2020
EVP & Chief Financial Officer
Sold, plan not stated
5,889
$63.36K
3.1%
2 Mar 2020
EVP & Chief Financial Officer
Sold, plan not stated
12,968
$132.09K
6.3%
2 Jan 2020
EVP & Chief Financial Officer
Sold, plan not stated
4,020
$64.09K
1.9%
4 Mar 2019
EVP & Chief Financial Officer
Sold, plan not stated
8,751
$173.96K
4.0%
1 Mar 2019
EVP & Chief Financial Officer
Sold, plan not stated
4,976
$100.27K
2.2%
3 Jan 2019
EVP & Chief Financial Officer
Sold, plan not stated
1,619
$42.23K
0.8%
2 Jan 2019
EVP & Chief Financial Officer
Sold, plan not stated
4,442
$117.58K
2.2%
1 Mar 2018
EVP & Chief Financial Officer
Sold, plan not stated
8,532
$159.71K
4.1%
2 Jan 2018
EVP & Chief Financial Officer
Sold, plan not stated
9,155
$140.49K
5.2%
3 Jan 2017
SVP, CFO & Treasurer
Sold, plan not stated
10,895
$169.01K
13.5%
4 Jan 2016
SVP, CFO, Sec & Treasurer
Sold, plan not stated
9,564
$85.69K
13.6%
10 Mar 2015
SVP, CFO, Sec & Treasurer
Sold, plan not stated
12,450
$131.10K
18.9%
19 Nov 2013
SVP, CFO, Sec & Treasurer
Sold, plan not stated
3,348
$40.42K
10.4%
16 Feb 2012
SVP, CFO, Sec & Treasurer
Sold, plan not stated
4,920
$22.99K
28.1%
29 Aug 2011
SVP, CFO, Sec & Treasurer
Bought
5,000
$29.95K
opened
15 decisions on file.